PGP and chronic myelogenous leukemia, BCR-ABL1 positive: This phenomenon could be explained by the role of P-gp, an efflux protein of IM proposed to be associated with imatinib resistance in CML patients (Mahon et al., 2003; Peng et al., 2012).